National Aeronautics and Space Administration August 7, 2014 – Federal Register Recent Federal Regulation Documents

This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the inventions described and claimed in USPN 8,338,114, Engineering Human Broncho-Epithelial Tissue-Like Assemblies, NASA Case No. MSC-24164-1; US Patent Application Serial Number 12/899,815, Modifying the Genetic Regulation of Bone and Cartilage Cells and Associated Tissue by EMF Stimulation Fields and Uses Thereof, NASA Case No. MSC-24541-1; and US Patent Application Serial Number 13/859,180, Alternating Ionic Magnetic Resonance (AIMR) Multiple-Chambered Culture Apparatus, NASA Case No. MSC-25545-1; and US Patent Application Serial Number 13/859,206, Methods for Culturing Cells in an Alternating Ionic Magnetic Resonance (AIMR) Multiple-Chambered Culture Apparatus, NASA Case No. MSC-25633-1, to GRoK Technologies, LLC, having its principal place of business in Houston, Texas. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.